Literature DB >> 32634383

Poor Late Outcomes After Tricuspid Valve Repair in a Single Ventricle: Experience of 103 Patients.

Celest Dines Muntaner1, Gregory King2, Diana Zannino3, Nelson Alphonso4, Kirsten Finucance5, David Winlaw6, Christian Brizard1, Robert Weintraub7, Yves d'Udekem8.   

Abstract

BACKGROUND: Outcomes of tricuspid valve repair in single-ventricle palliation are poor. We sought to identify the impact of repair technique and primary mechanisms of regurgitation on outcomes after surgery.
METHODS: A retrospective review of medical records across 4 centers undertaking single-ventricle palliation in Australia and New Zealand was performed. Patients with a dominant right functional single ventricle undergoing tricuspid valve repair between January 1991 and March 2019 were identified.
RESULTS: One hundred three patients met inclusion criteria, with a median follow-up duration of 6.7 years (interquartile range, 1.5-12.4). Mechanism of regurgitation was structural in 30 patients, functional in 28 patients, and a combination of both in 24 patients (21 missing). Surgical repair technique consisted of annuloplasty in 42 patients, leaflet and/or subvalvular repair in 12 patients, and a combination of both in 44 patients (5 missing). Thirty-four patients died, and 5 underwent heart transplantation. Fifty-two patients experienced valve repair failure (22 re-repairs, 7 replacements, and 23 recurrent regurgitation). Of 17 patients with early valve repair failure (within 30 days of repair), 14 died. Freedom from death or transplant at 5 years after repair for patients with a successful repair was 79% (95% confidence interval, 70%-90%) compared with 15% (95% confidence interval, 6%-37%) for those with a failed repair (P < .01; hazard ratio, 8.95; 95% confidence interval, 4%-18%).
CONCLUSIONS: Tricuspid valve repair failure occurs frequently in patients with a single ventricle and is associated with a significant risk of mortality. The persistence of moderate regurgitation after repair mandates reoperation.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 32634383     DOI: 10.1016/j.athoracsur.2020.05.070

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Melody valve-in-valve implantation in the tricuspid position through a Fontan conduit fenestration.

Authors:  Daniel Duarte; Lourdes Rosa Prieto; Patcharapong Suntharos
Journal:  Ann Pediatr Cardiol       Date:  2022-08-19

2.  Fontan candidacy, optimizing Fontan circulation, and beyond.

Authors:  Alyssia Venna; Frank Cetta; Yves d'Udekem
Journal:  JTCVS Open       Date:  2021-12-14

3.  A pilot investigation of the tricuspid valve annulus in newborns with hypoplastic left heart syndrome.

Authors:  Colton J Ross; Elizabeth J Trimble; Emily L Johnson; Ryan Baumwart; Matthew A Jolley; Arshid Mir; Harold M Burkhart; Chung-Hao Lee
Journal:  JTCVS Open       Date:  2022-02-24

4.  Outcomes and risk analysis after tricuspid valve surgery for non-Ebstein 2-ventricle congenital tricuspid valve diseases.

Authors:  David Blitzer; Ismail Bouhout; Eliana Al Haddad; Matthew Lewis; Kanwal Farooqi; Amee Shah; Noa Zemer-Wassercug; Harsimran Singh; Brett Anderson; Emile Bacha; David Kalfa
Journal:  JTCVS Open       Date:  2022-07-05

5.  Mechanical tricuspid valve replacement in hypoplastic left heart syndrome: An institutional experience.

Authors:  Mehar Hoda; Robert Douglas Benjamin Jaquiss; Lorraine James; Poonam Punjwani Thankavel
Journal:  JTCVS Open       Date:  2022-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.